Skip to main content

Table 2 Patient characteristics

From: Bortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial

Patients enrolled 18
Sex  
   Male 10
   Female 8
Age, years  
   Median 62
   Range 46–77
ECOG status  
   0 4
   1 12
   2 2
Cancer Type  
   Adrenocortical 1
   Colon 2
   Esophageal 1
   Fallopian Tube 1
   Hepatocellular 1
   Leiomyosarcoma 1
   Non-Small Cell Lung Carcinoma 1
   Ovarian 1
   Pancreatic 3
   Renal Cell 2
   Squamous Cell 2
   Transitional Cell 1
   Unknown Primary 1
Previous lines of chemotherapy  
   0–3 11
   4–6 5
   >6 2